ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 41 filers reported holding ONCOLYTICS BIOTECH INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $449,240 | -11.4% | 201,453 | +3.3% | 0.06% | -10.3% |
| Q2 2023 | $506,904 | +123.9% | 194,963 | +3.4% | 0.07% | +106.1% |
| Q1 2023 | $226,348 | -24.4% | 188,623 | +2.6% | 0.03% | +6.5% |
| Q4 2022 | $299,566 | +34.3% | 183,783 | +1.2% | 0.03% | -35.4% |
| Q3 2022 | $223,000 | +22.5% | 181,576 | +0.7% | 0.05% | +200.0% |
| Q2 2022 | $182,000 | -36.1% | 180,326 | 0.0% | 0.02% | -68.6% |
| Q1 2022 | $285,000 | +18.3% | 180,326 | +3.9% | 0.05% | +21.4% |
| Q4 2021 | $241,000 | -32.5% | 173,511 | +1.7% | 0.04% | -33.3% |
| Q3 2021 | $357,000 | -20.3% | 170,576 | +5.4% | 0.06% | -24.1% |
| Q2 2021 | $448,000 | -49.4% | 161,826 | -41.8% | 0.08% | +1.2% |
| Q1 2021 | $885,000 | +208.4% | 277,852 | +130.1% | 0.08% | +57.7% |
| Q4 2020 | $287,000 | +81.6% | 120,776 | +29.3% | 0.05% | +33.3% |
| Q3 2020 | $158,000 | +159.0% | 93,411 | +185.8% | 0.04% | +160.0% |
| Q2 2020 | $61,000 | +205.0% | 32,687 | +131.2% | 0.02% | +150.0% |
| Q1 2020 | $20,000 | – | 14,139 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 173,511 | $241,000 | 0.04% |
| Advisor Resource Council | 100,000 | $139,000 | 0.01% |
| BRAVE ASSET MANAGEMENT INC | 20,000 | $28,000 | 0.01% |
| Aquatic Capital Management LLC | 2,600 | $4,000 | 0.01% |
| Long Focus Capital Management, LLC | 40,000 | $56,000 | 0.01% |
| Newman Dignan & Sheerar, Inc. | 13,915 | $19,000 | 0.01% |
| Disciplined Investments, LLC | 5,189 | $7,000 | 0.00% |
| Cedar Mountain Advisors, LLC | 5,651 | $8,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 27,125 | $38,000 | 0.00% |
| SITTNER & NELSON, LLC | 1,000 | $1,000 | 0.00% |